Evidence map›Paper›PMID 36393869›Full record

ArticleFrontiers in cell and developmental biology2022

Metformin promotes

Yongzhi Cao, Zhao Wang, Changming Zhang, Yuehong Bian, Xin Zhang, Xin Liu, Wendi Chen, Yueran Zhao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yongzhi CaoCenter for Reproductive Medicine, Shandong University, Jinan, Shandong, China.
Zhao WangCenter for Reproductive Medicine, Shandong University, Jinan, Shandong, China.
Changming ZhangCenter for Reproductive Medicine, Shandong University, Jinan, Shandong, China.
Yuehong BianCenter for Reproductive Medicine, Shandong University, Jinan, Shandong, China.
Xin ZhangCenter for Reproductive Medicine, Shandong University, Jinan, Shandong, China.
Xin LiuCenter for Reproductive Medicine, Shandong University, Jinan, Shandong, China.
Wendi ChenCenter for Reproductive Medicine, Shandong University, Jinan, Shandong, China.
Yueran ZhaoCenter for Reproductive Medicine, Shandong University, Jinan, Shandong, China.
Shandong University · CNShandong Maternal and Child Health Hospital · CNShandong Provincial Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human female fecundity decreases irreversibly as chronological age rises, adversely affecting oocyte quality, consequently worsening pregnancy outcomes and increasing the extent of birth defects. The first-line type 2 diabetes treatment metformin has been associated with delayed aging and reduction of oxidative stress; yet it remains unclear if metformin confers any benefits for oocytes from aged mice, particularly in the context of the assisted human reproductive technology (ART) known as

Indexed as

aged miceIVMmetforminoocytesROS

Identifiers

PMID36393869
PMCPMC9640937
OpenAlexW4309412971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.